Mexico Agrees to Host Irans World Cup Squad Amid USIran Tensions Says President Sheinbaum Unretirement Wave Older Americans Return to Workforce Driven by Financial Needs and Purpose Ashiana Housing Reports Flat Q4 Profit Revenue Rises to Rs 335 Crore FY26 Net Profit Surges Microsoft Appoints Accessibility Veteran to Lead Responsible AI Development Amid Speed vs Safety Tensions Obsession Approaches Box Office Milestones Amid Growing Theatrical Demand SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms AVTR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 3 HYMC Q3 2025 Earnings Narrower Loss Surprises Estimates as Company Advances Operations SLN Q4 2024 Earnings Positive EPS Surprise Drives Stock Rally Amid Revenue Absence LTC Properties Inc Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter INGR Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher DBX Q1 2026 Earnings EPS Beat Signals Resilience Despite Revenue Uncertainty Molina Healthcare MOH Sees Modest Gains Tests Midpoint of Recent Range Agenus AGEN Rallies 22 Biotech Momentum Faces Key Resistance at 356 Werewolf Therapeutics HOWL Stages a Modest Rebound Can the 044 Level Hold West Pharmaceutical Services WST Gains Ground Technical Rebound Underway BlackRock Science and Technology Trust BST Gains 231 as Tech Sentiment Lifts Prices Kevin Warshs Potential Fed Overhaul A Shift in Wall Streets Plumbing SMMT Q1 2026 Earnings EPS Misses Street Expectations While Pipeline Momentum Continues AN2 Therapeutics ANTX Slides 43 as Shares Test Key Support at 421 GD Q1 2026 Earnings EPS Beats Estimates by 82 Stock Rises ENDRA Life Sciences Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Continues Development SPME Q1 2026 Earnings Preferred Shares Miss EPS Estimates Stock Declines United Rentals URI Q1 2026 Earnings Solid EPS Beat Powered by Operational Strength MCRI Q1 2026 Earnings EPS Surges Past Estimates by 349 ORRF Q1 2026 Earnings EPS Beats Estimates by 908 Stock Declines Slightly CGON Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment